The impact of Medicare's lifetime immunosuppression coverage on racial disparities in kidney graft survival

American Journal of Transplantation

Volumn 12, Issue 6, 2012, Pages 1519-1527

  Page, T F ^a   Woodward, R S ^b   Brennan, D C ^c  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UNIVERSITY OF NEW HAMPSHIRE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Graft survival; immunosuppression medication; kidney transplantation; Medicare; racial disparities

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; COHORT ANALYSIS; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; GROUPS BY AGE; HEALTH CARE POLICY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCOME; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME;

CONTINENTAL POPULATION GROUPS; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MEDICARE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; UNITED STATES;

EID: 84861792489     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03974.x     Document Type: Article

References (14)

1. Young CJ, Gaston RS,. Renal transplantation in black Americans. N Engl J Med 2000; 343: 1545-1552.
2. Young CJ, Gaston RS,. African American's and Renal Transplantation: Disproportionate need, limited access, and impaired outcomes. Am J Med Sci 2002; 323: 94-99.
3. Isaacs RB, Nock SL, Connors AF Jr., Wang XQ, Sawyers R, Lobo PI,. Racial disparities in renal transplant outcomes. Am J Kidney Dis 1999; 34: 706-712.
4. Kalil RS, Heim-Duthoy KL, Kasiske BL,. Patients with a low income have reduced renal allograft survival. Am J Kidney Dis 1992; 20: 63-69.
5. Woodward RS, Schnitzler MA, Lowell JA, Spitznagel EL,. Effect of extending coverage of immunosuppressive medications by medicare on the survival of cadaveric renal transplants. Am J Transplant 2001; 1: 69-73.
6. Woodward RS, Page TF, Soares RB, Schnitzler MA, Lentine KL, Brennan DC,. Income-related disparities in kidney transplant graft failures are eliminated by Medicare's immunosuppression coverage. Am J Transplant 2008; 8: 2636-2646.
7. Hricik DE, Whalen CC, Lautman J, et al,. Withdrawal of steroids after renal Transplantation-Clinical predictors of outcome. Transplantation 1992; 53: 41-45.
8. Sanders CE, Curtis JJ, Kulian BA, et al,. Tapering or discontinuing cyclosporine for financial reasons-A single center experience. Am J Kidney Dis 1993; 21: 9-15.
9. Pallet N, Thervet E, Alberti C, et al,. Kidney transplant in black recipients: Are African Europeans different from African Americans? Am J Transplant 2005; 5: 2682-2687.
10. Gordon EJ, Caicedo JC,. Ethnic advantages in kidney transplant outcomes: The Hispanic Paradox at work? Nephrol Dial Transplant 2009; 24: 1103-1109.
11. Eckhoff EE, Young, CJ, Gaston, RS, et al,. Racial disparities in renal allograft survival: A public health issue? JACS 2007; 204: 894-902.
12. Padiyar A, Augustine JJ, Bodziak KA, Aeder M, Schulak JA, Hricik DF,. Influence of African American ethnicity on acute rejection after early steroid withdrawal in primary kidney transplant recipients. Transplant Proc 2010; 42: 1643-1647.
13. Ojo AO, Port FK, Held PJ, et al,. Inferior outcome of two-haplotype matched renal transplants in blacks: Role of early rejection. Kidney Int 1995; 48: 1592-1599.
14. Freedman LS,. Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1982; 1: 121-129.